Lv5
952 积分 2025-05-16 加入
Effect of ursodeoxycholic acid on glycemic markers: A systematic review and meta-analysis of clinical trials
6天前
已完结
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
8天前
已完结
Exploring the next generation of antibody–drug conjugates
9天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
10天前
已完结
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
17天前
已完结
A first-in-class JAK/ROCK inhibitor, Rovadicitinib in patients with myelofibrosis who were refractory or relapsed or intolerant to Ruxolitinib: A single-arm, multicenter, open-label, phase Ib study
20天前
已完结
Novel Janus-kinase (JAK) Inhibitors in Myelofibrosis
20天前
已完结
A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD
21天前
已完结
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
24天前
已完结
Evaluating biased agonism of glucagon‐like peptide‐1 (GLP‐1) receptors to improve cellular bioenergetics: A systematic review
1个月前
已关闭
皖公网安备34019202002308
